Literature DB >> 35381609

Maternal Diabetes and Intrapartum Fetal Electrocardiogram.

Beth A Plunkett1, Steven J Weiner2, George R Saade3, Michael A Belfort4, Sean C Blackwell5, John M Thorp6, Alan T N Tita7, Russell S Miller8, David S McKenna9, Edward K S Chien10, Dwight J Rouse11, Yasser Y El-Sayed12, Yoram Sorokin13, Steve N Caritis14.   

Abstract

OBJECTIVE: Fetal electrocardiogram (ECG) ST changes are associated with fetal cardiac hypoxia. Our objective was to evaluate ST changes by maternal diabetic status and stage of labor.
METHODS: This was a secondary analysis of a multicentered randomized-controlled trial in which laboring patients with singleton gestations underwent fetal ECG scalp electrode placement and were randomly assigned to masked or unmasked ST-segment readings. Our primary outcome was the frequency of fetal ECG tracings with ST changes by the stage of labor. ECG tracings were categorized into mutually exclusive groups (ST depression, ST elevation without ST depression, or no ST changes). We compared participants with DM, gestational diabetes mellitus (GDM), and no DM.
RESULTS: Of the 5,436 eligible individuals in the first stage of labor (95 with pregestational DM and 370 with GDM), 4,427 progressed to the second stage. ST depression occurred more frequently in the first stage of labor in participants with pregestational DM (15%, adjusted odds ratio [aOR] 2.20, 95% confidence interval [CI] 1.14-4.24) and with GDM (9.5%, aOR 1.51, 95% CI 1.02-2.25) as compared with participants without DM (5.7%). The frequency of ST elevation was similar in participants with pregestational DM (33%, aOR 0.79, 95% CI 0.48-1.30) and GDM (33.2%, aOR 0.91, 95% CI 0.71-1.17) as compared with those without DM (34.2%). In the second stage, ST depression did not occur in participants with pregestational DM (0%) and occurred more frequently in participants with GDM (3.5%, aOR 2.01, 95% CI 1.02-3.98) as compared with those without DM (2.0%). ST elevation occurred more frequently in participants with pregestational DM (30%, aOR 1.81, 95% CI 1.02-3.22) but not with GDM (19.0%, aOR 1.06, 95% CI 0.77-1.47) as compared with those without DM (17.8%).
CONCLUSION: ST changes in fetal ECG occur more frequently in fetuses of diabetic mothers during labor. CLINICALTRIALS: gov number, NCT01131260. PRECIS: ST changes in fetal ECG, a marker of fetal cardiac hypoxia, occur more frequently in fetuses of diabetic parturients. KEY POINTS: · Fetal hypertrophic cardiomyopathy (HCM) and cardiac dysfunction occur frequently among fetuses of diabetic patients.. · Fetal ECG changes such as ST elevation and depression reflect cardiac hypoxia.. · Fetuses of diabetic patients demonstrate a higher prevalence of fetal ECG tracings with ST changes.. Thieme. All rights reserved.

Entities:  

Year:  2022        PMID: 35381609      PMCID: PMC9532457          DOI: 10.1055/a-1817-5788

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   3.079


  25 in total

1.  ST waveform changes during repeated umbilical cord occlusions in near-term fetal sheep.

Authors:  J A Westgate; L Bennet; C Brabyn; C E Williams; A J Gunn
Journal:  Am J Obstet Gynecol       Date:  2001-03       Impact factor: 8.661

2.  Infants of diabetic mothers: echocardiographic measurements and cord blood IGF-I and IGFBP-1.

Authors:  Mona M El-Ganzoury; Sahar A El-Masry; Rania A El-Farrash; Mona Anwar; Rasha Z Abd Ellatife
Journal:  Pediatr Diabetes       Date:  2011-09-20       Impact factor: 4.866

3.  Cardiotocography plus ST analysis of fetal electrocardiogram compared with cardiotocography only for intrapartum monitoring: a randomized controlled trial.

Authors:  Michelle E M H Westerhuis; Gerard H A Visser; Karel G M Moons; Erik van Beek; Manon J Benders; Saskia M Bijvoet; Hendrikus J H M van Dessel; Addy P Drogtrop; Herman P van Geijn; Giuseppe C Graziosi; Floris Groenendaal; Jan M M van Lith; Jan G Nijhuis; S Guid Oei; Herman P Oosterbaan; Martina M Porath; Robbert J P Rijnders; Nico W E Schuitemaker; Louisa M Sopacua; Ingeborg van der Tweel; Lia D E Wijnberger; Christine Willekes; Nicolaas P A Zuithoff; Ben Willem J Mol; Anneke Kwee
Journal:  Obstet Gynecol       Date:  2010-06       Impact factor: 7.661

4.  Electrocardiographic changes following umbilical cord occlusion in the midgestation fetal sheep.

Authors:  Anna-Karin Welin; Sofia Blad; Henrik Hagberg; K G Rosén; Ingemar Kjellmer; Carina Mallard
Journal:  Acta Obstet Gynecol Scand       Date:  2005-02       Impact factor: 3.636

5.  [Natural history of myocardial hypertrophy and its association with hyperinsulinism in infants of diabetic mothers].

Authors:  P Zielinsky; M H da Costa; L T Oliveira; F P Bonow; N I da Silva; L L Hagemann
Journal:  Arq Bras Cardiol       Date:  1997-12       Impact factor: 2.000

6.  Myocardial metabolism in relation to electrocardiographic changes and cardiac function during graded hypoxia in the fetal lamb.

Authors:  K H Hökegård; B O Eriksson; I Kjellmer; R Magno; K G Rosén
Journal:  Acta Physiol Scand       Date:  1981-09

7.  Prevalence of Hypertrophic Cardiomyopathy in Fetuses of Mothers with Gestational Diabetes before Initiating Treatment.

Authors:  Carolina Rossi Palmieri; Mona Adalgisa Simões; Jean Carl Silva; Anelise Darabas Dos Santos; Mariana Ribeiro E Silva; Bruna Ferreira
Journal:  Rev Bras Ginecol Obstet       Date:  2017-02-28

8.  Elevated neonatal insulin-like growth factor I is associated with fetal hypertrophic cardiomyopathy in diabetic women.

Authors:  Anna B Gonzalez; Luciana Young; Jennifer A Doll; Gina M Morgan; Susan E Crawford; Beth A Plunkett
Journal:  Am J Obstet Gynecol       Date:  2014-05-09       Impact factor: 8.661

9.  Alterations in the electrocardiogram of the fetal lamb as a sign of fetal asphyxia. A comparison between the scalp lead and the precordial lead.

Authors:  K H Hökegård; K G Rosén
Journal:  Acta Obstet Gynecol Scand       Date:  1980       Impact factor: 3.636

10.  Maternal diabetic control and hypertrophic cardiomyopathy in infants of diabetic mothers.

Authors:  P Q Sheehan; T W Rowland; B L Shah; V J McGravey; E O Reiter
Journal:  Clin Pediatr (Phila)       Date:  1986-05       Impact factor: 1.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.